STAT+: What Medicare incentives for AI-based devices mean for tech companies — and hospitals
Reported by STAT News · all stories from statnews.com
Editorial digest
Medicare's financial incentives for artificial intelligence-powered devices hold significant implications for both technology firms and healthcare organizations. These policies shape adoption and innovation.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/13/2026
STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices
An investigation examines Commure and Medicare's AI device incentives.
- Trusted health newsroom9/15/2026
STAT+: Medicare’s AI prior authorization pilot was rushed and full of problems, new documents reveal
Medicare's AI prior authorization program faced issues and was launched too quickly, according to new details.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.
- Trusted health newsroom8/27/2026
STAT+: CMS plans launch event for ACCESS, the Medicare chronic care pilot
CMS is preparing an event for its new chronic care pilot, ACCESS.
- Trusted health newsroom9/9/2026
STAT+: U.K. unveils recommendations for regulating AI in medicine
The U.K. has published guidelines for regulating AI in medical applications.
- Trusted health newsroom9/14/2026
STAT+: How $500 explains Republican health policy, and the GLP-1 Rx wave
A specific financial figure illuminates Republican health policy and the rise of GLP-1 prescriptions.